Previous 10 |
home / stock / hkmpf / hkmpf news
Hikma Pharmaceuticals plc. (HKMPF) Q4 2017 Earnings Conference Call March 14, 2017 05:30 am ET Executives Said Darwazah - Executive Chairman Khalid Nabilsi - Chief Financial Officer Siggi Olafsson - Chief Executive Officer Riad Mishlawi - CEO, Injectables Division Analysts ...
Hikma Pharmaceuticals ( OTCPK:HKMPF ): FY EPS of $1.05 More news on: Hikma Pharmaceuticals plc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc Company Name:
HKMPF Stock Symbol:
OTCMKTS Market:
Hikma Pharmaceuticals Plc Website:
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...
Verbund AG ADR (OEZVY) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-6.56 for Q1 2025 Johnson Matthey plc ADR (JMPLY) is expected to report for Q4 2024 RVL Pharmaceuticals plc (RVLPQ) is expected to report for Q1 2024 Ciena Corporation (CIEN...